AFT Pharmaceutical's multi-billion R&D opportunity
Welcome to HotCopper’s latest Watchlist, where we’ve been joined by AFT Pharmaceuticals (ASX:AFP) founder and chief executive Hartley Atkinson to discuss its expanding global reach and the @tentative” FDA approval the company has just hauled i...
Market Cap $26.38M
!
Reach your audience today.

Corporate Spotlight
Announcements
Filter Results
| NVO | Launch of new Enterprise Platform | PRICE SENSITIVE | 10/04/18 | |
| NVO | TechKnow Investor Presentation | 10/04/18 | ||
| NVO | Commercialisation and Outlook for 2018 | PRICE SENSITIVE | 04/04/18 | |
| NVO | December half year results | 21/02/18 | ||
| NVO Launch of new Enterprise Platform | |||
| 10/04/18 | PRICE SENSITIVE | ||
| NVO TechKnow Investor Presentation | |||
| 10/04/18 | |||
| NVO Commercialisation and Outlook for 2018 | |||
| 04/04/18 | PRICE SENSITIVE | ||
| NVO December half year results | |||
| 21/02/18 | |||
